In vitro analysis shows cerium oxide nanoparticles enhance apoptosis in cancer cells, indicating potential for targeted therapies.
Citrate-stabilized cerium oxide nanoparticles (CeO2 NPs) with ultrasmall size (2–4 nm) were synthesized and comprehensively characterized, demonstrating high colloidal stability and favorable redox properties. Their radioprotective and radiosensitizing potential was evaluated in aqueous systems and in vitro using human mesenchymal stem cells (hMSCs) and MCF-7 breast cancer cells. CeO2 NPs exhibited concentration-dependent catalytic activity, efficiently scavenging hydrogen peroxide and hydroxyl radicals under X-ray irradiation. In hMSCs, CeO2 NPs promoted proliferation, reduced apoptosis, and attenuated DNA double-strand breaks, thereby conferring radioprotection. In contrast, in MCF-7 cells, CeO2 NPs enhanced ROS accumulation, disrupted cell-cycle checkpoints, increased γ-H2AX foci, and sensitized cells to radiation-induced apoptosis. Gene expression profiling revealed differential regulation of oxidative stress and apoptosis pathways consistent with selective protection of normal cells and radiosensitization of cancer cells. These findings highlight the dual redox-dependent activity of CeO2 NPs and support their potential application as nanomaterials for radioprotection and radiosensitization.
No takes yet. Share an insight, caveat, or question.
Popova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: